Primary hepatic lymphoma in a patient with Sjögren's syndrome.
We report a case of primary hepatic lymphoma (PHL) that developed in a patient with well controlled Sjogren's syndrome (SS) who had been receiving long-term prednisolone treatment. The tumor, found incidentally by ultrasonography, was shown as an extremely large, solitary liver mass that exhibited the immunohistological features of a B-cell lymphoma. An intensive regimen of chemotherapy induced complete regression of this mass. SS occasionally gives rise to lymphoma in salivary glands, however, there have been no previous reports of PHL in a patient with SS. This case study raises the possibility that SS itself, a form of autoimmune disease, and/or prednisolone-based immunosuppressive treatment for SS, predisposes to the occurrence of PHL. SS patients should be monitored vigilantly for the occurrence of extranodal lymphoma, including PHL, even if the SS is well controlled.
Tsuruta
Satoru
S
Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Enjoji
Munechika
M
Nakamuta
Makoto
M
Makihata
Tetsuji
T
Kotoh
Kazuhiro
K
Sakai
Hironori
H
Ando
Bun-Ei
BE
Nawata
Hajime
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D016393:Lymphoma, B-Cell / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012859:Sjogren's Syndrome / Q000150:complications*; D016896:Treatment Outcome; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone